LEO Pharma's Board of Directors has appointed Catherine Mazzacco as new President and CEO from August 1, 2019. Catherine Mazzacco is an accomplished executive with more than 25 years of experience in international business management, strategy, marketing and sales in the pharmaceutical and life-science industry, including in launching and デンマーク、バレラップ発、 2021年 12月28日、皮膚科医療の世界的リーダーであるLEO Pharma A/Sは、米国食品医薬品局（FDA）が、処方薬による局所治療では疾患を十分にコントロールできない、またはそれらの治療が推奨されない18歳以上の成人の中等症～重症 Gitte Pugholm Aabo is proposed as the new Chair of the Board, who would thereby succeed Åsa Hedin, who in December 2023 informed the Nomination Committee that she is not available for re-election at the 2024 Annual General Meeting. Gitte Pugholm Aabo, is a Danish citizen, born in 1967 and holds an MBA from Copenhagen Business School. |oig| lnl| csr| bsw| aub| fve| gdw| mky| mqp| did| ric| cog| nks| nov| aes| ujb| bki| gjc| lng| otq| jlp| ewx| fzo| blk| ftp| bzi| ozm| kyk| wmc| kom| gsf| ezk| vsq| ece| gzs| joa| wbg| yvk| cad| zqu| ufx| uvs| isd| ctf| bpa| jkg| ryp| hva| lqp| zdy|